Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
Dicerna Pharmaceuticals, Inc. engages in the discovery, research, and development of treatments based on RNAi technology platform. It uses its proprietary RNA interference technology platform, which it believes improves on existing RNAi technologies, to build a broad pipeline in these... More
Country: United States
Other News & PR